ALIMTAS BIOVENTURES
LIFE SCIENCE ENTREPRENEURSHIP
Alimtas works directly with the Office of Technology Licensing to spin out Princeton University life science discoveries spanning biotechnology, therapeutics, medical technologies, and other subfields from researchers through rigorous due diligence and business planning. Alimtas also partners with leading life science venture capital firms and industry companies to deepen members’ knowledge, methodologies, and networks.
DIRECTORS
DANIEL TAN
CBE ‘25
“Why not join a group full of talented kids with ideas and the time/energy to execute on them? Early-stage strategy is wildly interesting to me and I enjoy seeing from both sides of the dealmaking table how projects and companies form, stay afloat, succeed, and fail. Teams like Alimtas help me learn such things while giving me the opportunity to broaden my knowledge of the biotech sector, bond closely with peers that never cease to amaze me with their brilliance, and meet many professionals with stories to tell and lessons to teach.”
I'm a junior in CBE from the Bay Area and am broadly interested in bioinformatics, biophysics, novel ways to apply machine learning methods to characterize biological systems, and the ideals of model interpretability and generativity. I am a student researcher in the Joseph Group, and my work revolves around characterizing biomolecular condensates in silico. In a less stressful world, I really enjoy sketching, sewing, reading, playing instruments, and being in nature for hours on end.
ELANA SVERDIK
ECE ‘24
“As an aspiring leader in biotechnology, I joined E-Club because I am keenly interested in developing key entrepreneurial skills and reaching a deeper strategic understanding of biotech innovation and entrepreneurship. Throughout my past three years in the Alimtas Bioventures I have been grateful to build connections with a network of key opinion leaders from whom I learned about the approval processes, the scope of intellectual property, and appropriate validation assays for commercializing a variety of different biological technologies. I’m beyond grateful for the opportunity to lead a team of the brightest and most diligent student entrepreneurs through in-depth market research and pitch rounds this year!”
I am a senior in the Electrical and Computer Engineering (ECE) department and I am interested in creating minimally invasive technologies to interface with the human body with an overarching goal to improve human healthspan. I am originally from Marin County, California and I have also lived in Southern California and Florida. In my free time I sing second alto in Princeton's oldest all-female identifying a capella group, The Princeton Tigerlilies!
MAYA BUTANI
MOL ‘26
“I've had a longstanding interest in research and biomedical sciences. Through entrepreneurship, I hoped to translate scientific developments into tangible treatments, and I sought to gain more experience in this space through E-Club. Ultimately, my professional experiences in E-Club have been so eye-opening, but I've valued the community most. E-Club fosters a wonderful opportunities to meet and develop relationships with like-minded peers. As friends and mentors, my teammates in E-Club have been instrumental in my development as an entrepreneur, student, and person.”
I am a molecular biology major from New Jersey with an interest in biotechnology, and increasing medical accessibility and efficacy from the lab. On campus, I'm a director for Alimtas Bioventures, an officer for the Princeton Biotech Group, an Orange Key tour guide, and a part of Service Focus. Beyond extracurriculars and academics I love to run, spend time outside, and meet new people!
what we do
Through partnership with Office of Technology Licensing, we receive a new key piece of Princeton IP/Technology in the life sciences to work on every semester
We conduct a deep dive on the technology and current research to understand the competitive landscape
We assess commercialization pathways, which include clinical trial requirements, potential partnerships, funding requirements and opportunities, and licensing opportunities
At the end of the semester, we provide a deliverable presentation and comprehensive business plan detailing how the business can be formed and the product brought to market
HIGHLIGHTS
2020-21 (SPRING)
2020-21 (FALL)
2019-2020
The team created a pitch deck about a gene therapy promoter for increased genetic payload and long term expression invented by Professor Esteban Engel (NEU) and will be pitching the deck to leaders in the field in the early Fall Semester (Sep. 2021).
The team finalized a licensing deal for a high-throughput SARS-CoV-2 replicon model invented by Professor Alexander Ploss (MOL) and virtually pitched the deck to multiple biotechnology companies and venture capital firms, collecting invaluable feedback along the way (Dec. 2020).
The team created a complete pitch deck for Professor Alexander Ploss of Molecular Biology’s novel HBV technology and successfully pitched the deck to leaders in the field, collecting valuable feedback along the way (Dec. 2019)
our partners
Princeton Innovation Center BioLabs | Princeton Office of the Dean of Undergraduate Students | Princeton Entrepreneurship Council | Princeton Office of Technology Licensing | New Jersey Health Foundation | Keller Center for Innovation in Engineering Education | Merck | Regeneron | Gilead | Alynylam | Eli Lilly
